This week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts. Listen ...

Shares of several pharmaceutical companies were up after President Trump signed an executive order aimed at accelerating research, development access to psychedelic medicines for the treatment of ...

Regeneron is the latest pharmaceutical manufacturer to make a deal with the administration to offer some of their drugs at ...

Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech ...

On April 8, 2026, Bernstein upgraded Takeda Pharmaceutical Company Limited (NYSE:TAK) to Outperform from Market Perform and ...

President Donald Trump is set to announce a drug pricing agreement with pharmaceutical company Regeneron, marking the final ...

Arrowhead Pharmaceuticals could notch more gains as the biotechnology firm prepares to release data tied to clinical trials ...

(NASDAQ:KYMR) is among the best biotech stocks. TheFly reported on April 13 that KYMR announced that the U.S. Food and Drug ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. As President Trump hails ...

On Wednesday, pharma giant AbbVie announced a $1.4 billion investment to build a 185-acre pharmaceutical manufacturing campus ...

The full picture of Replimune's layoffs is coming into focus — and more employees are on the chopping block than previously ...